Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Change in Inventory (2020 - 2025)

Maxcyte (MXCT) has disclosed Change in Inventory for 6 consecutive years, with $107000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory rose 5450.0% to $107000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.2 million, a 201.8% decrease, with the full-year FY2024 number at -$1.4 million, down 130.04% from a year prior.
  • Change in Inventory was $107000.0 for Q3 2025 at Maxcyte, up from -$223000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.7 million in Q1 2023 to a low of -$664000.0 in Q2 2024.
  • A 5-year average of $390726.3 and a median of $241200.0 in 2022 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: plummeted 218.16% in 2024, then soared 5450.0% in 2025.
  • Maxcyte's Change in Inventory stood at $1.1 million in 2021, then crashed by 44.62% to $612300.0 in 2022, then dropped by 27.16% to $446000.0 in 2023, then tumbled by 218.16% to -$527000.0 in 2024, then skyrocketed by 120.3% to $107000.0 in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Change in Inventory are $107000.0 (Q3 2025), -$223000.0 (Q2 2025), and -$531000.0 (Q1 2025).